239 related articles for article (PubMed ID: 29359063)
1. Seeking a New Paradigm for Alzheimer's Disease: Considering the Roles of Inflammation, Blood-Brain Barrier Dysfunction, and Prion Disease.
McCaulley ME; Grush KA
Int J Alzheimers Dis; 2017; 2017():2438901. PubMed ID: 29359063
[TBL] [Abstract][Full Text] [Related]
2. Alzheimer's Disease is Driven by Intraneuronally Retained Beta-Amyloid Produced in the AD-Specific, βAPP-Independent Pathway: Current Perspective and Experimental Models for Tomorrow.
Volloch V; Olsen B; Rits S
Ann Integr Mol Med; 2020; 2(1):90-114. PubMed ID: 32617536
[TBL] [Abstract][Full Text] [Related]
3. Emerging roles of astrocytes in blood-brain barrier disruption upon amyloid-beta insults in Alzheimer's disease.
Yue Q; Hoi MPM
Neural Regen Res; 2023 Sep; 18(9):1890-1902. PubMed ID: 36926705
[TBL] [Abstract][Full Text] [Related]
4. Contributions of blood-brain barrier imaging to neurovascular unit pathophysiology of Alzheimer's disease and related dementias.
Uchida Y; Kan H; Sakurai K; Oishi K; Matsukawa N
Front Aging Neurosci; 2023; 15():1111448. PubMed ID: 36861122
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer's disease (AD) therapeutics - 2: Beyond amyloid - Re-defining AD and its causality to discover effective therapeutics.
Mullane K; Williams M
Biochem Pharmacol; 2018 Dec; 158():376-401. PubMed ID: 30273552
[TBL] [Abstract][Full Text] [Related]
6. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
7. Activation of Wnt/β-catenin pathway mitigates blood-brain barrier dysfunction in Alzheimer's disease.
Wang Q; Huang X; Su Y; Yin G; Wang S; Yu B; Li H; Qi J; Chen H; Zeng W; Zhang K; Verkhratsky A; Niu J; Yi C
Brain; 2022 Dec; 145(12):4474-4488. PubMed ID: 35788280
[TBL] [Abstract][Full Text] [Related]
8. Vascular Dysfunction in Alzheimer's Disease: A Prelude to the Pathological Process or a Consequence of It?
Govindpani K; McNamara LG; Smith NR; Vinnakota C; Waldvogel HJ; Faull RL; Kwakowsky A
J Clin Med; 2019 May; 8(5):. PubMed ID: 31083442
[TBL] [Abstract][Full Text] [Related]
9. One or more β-amyloid(s)? New insights into the prion-like nature of Alzheimer's disease.
Catania M; Di Fede G
Prog Mol Biol Transl Sci; 2020; 175():213-237. PubMed ID: 32958234
[TBL] [Abstract][Full Text] [Related]
10. Do We Need Anti-Prion Compounds to Treat Alzheimer's Disease?
Willbold D; Kutzsche J
Molecules; 2019 Jun; 24(12):. PubMed ID: 31208037
[TBL] [Abstract][Full Text] [Related]
11. New developments in mild cognitive impairment and Alzheimer's disease.
Schott JM; Kennedy J; Fox NC
Curr Opin Neurol; 2006 Dec; 19(6):552-8. PubMed ID: 17102693
[TBL] [Abstract][Full Text] [Related]
12. High molecular mass assemblies of amyloid-β oligomers bind prion protein in patients with Alzheimer's disease.
Dohler F; Sepulveda-Falla D; Krasemann S; Altmeppen H; Schlüter H; Hildebrand D; Zerr I; Matschke J; Glatzel M
Brain; 2014 Mar; 137(Pt 3):873-86. PubMed ID: 24519981
[TBL] [Abstract][Full Text] [Related]
13. Impact of apolipoprotein E isoforms on sporadic Alzheimer's disease: beyond the role of amyloid beta.
Lozupone M; Panza F
Neural Regen Res; 2024 Jan; 19(1):80-83. PubMed ID: 37488848
[TBL] [Abstract][Full Text] [Related]
14. Time to test antibacterial therapy in Alzheimer's disease.
Panza F; Lozupone M; Solfrizzi V; Watling M; Imbimbo BP
Brain; 2019 Oct; 142(10):2905-2929. PubMed ID: 31532495
[TBL] [Abstract][Full Text] [Related]
15. Critical role of mitosis in spontaneous late-onset Alzheimer's disease; from a Shugoshin 1 cohesinopathy mouse model.
Rao CV; Farooqui M; Asch AS; Yamada HY
Cell Cycle; 2018; 17(19-20):2321-2334. PubMed ID: 30231670
[TBL] [Abstract][Full Text] [Related]
16. On the subject of rigor in the study of amyloid β-protein assembly.
Teplow DB
Alzheimers Res Ther; 2013; 5(4):39. PubMed ID: 23981712
[TBL] [Abstract][Full Text] [Related]
17. Beyond the amyloid hypothesis: how current research implicates autoimmunity in Alzheimer's disease pathogenesis.
Chatanaka MK; Sohaei D; Diamandis EP; Prassas I
Crit Rev Clin Lab Sci; 2023 Sep; 60(6):398-426. PubMed ID: 36941789
[TBL] [Abstract][Full Text] [Related]
18. Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease.
Nelson AR; Sweeney MD; Sagare AP; Zlokovic BV
Biochim Biophys Acta; 2016 May; 1862(5):887-900. PubMed ID: 26705676
[TBL] [Abstract][Full Text] [Related]
19. Peripheral Pathways to Neurovascular Unit Dysfunction, Cognitive Impairment, and Alzheimer's Disease.
Nelson AR
Front Aging Neurosci; 2022; 14():858429. PubMed ID: 35517047
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
